Verge Genomics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Verge Genomics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11034
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Verge Genomics Inc (Verge Genomics) is a drug discovery company that focuses on the discovery of treatments for neurodegenerative diseases using human genomic data and machine learning. The company combines large-scale molecular, genomic and genetic data on multiple platforms and technologies to map disease causing genes, and then matches them to drugs that target the total gene network. Verge’s genomic network approach provides a breakthrough opportunity that facilitates the identification of effective drugs and helps reduce the cost of drug development. Verge focuses on the creation of its proprietary datasets, generating comprehensive databases of ALS, and Alzheimer’s and Parkinson’s disease patients’ genomic data through partnerships with academic and government organizations. Verge Genomics is headquartered in San Francisco, California, the US.

Verge Genomics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Verge Genomics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Verge Genomics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Verge Genomics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Verge Genomics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Verge Genomics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Verge Genomics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Verge Genomics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Verge Genomics Raises USD32 Million in Series A Financing 11
Verge Genomics Raises USD4 Million in Seed Financing Round 13
Partnerships 14
Datavant Enters into Agreement with Verge Genomics 14
Verge Genomics Enters into Agreement with National Human Genome Research Institute, Scripps Research Institute and Center for Regenerative Therapies Dresden 15
Verge Genomics Enters into Agreement with Columbia University, Massachusetts General Hospital, University of Southern California, and University of Michigan 16
Verge Genomics Inc – Key Competitors 18
Verge Genomics Inc – Key Employees 19
Verge Genomics Inc – Locations And Subsidiaries 20
Head Office 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Verge Genomics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Verge Genomics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Verge Genomics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Verge Genomics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Verge Genomics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Verge Genomics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Verge Genomics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Verge Genomics Raises USD32 Million in Series A Financing 11
Verge Genomics Raises USD4 Million in Seed Financing Round 13
Datavant Enters into Agreement with Verge Genomics 14
Verge Genomics Enters into Agreement with National Human Genome Research Institute, Scripps Research Institute and Center for Regenerative Therapies Dresden 15
Verge Genomics Enters into Agreement with Columbia University, Massachusetts General Hospital, University of Southern California, and University of Michigan 16
Verge Genomics Inc, Key Competitors 18
Verge Genomics Inc, Key Employees 19

List of Figures
Verge Genomics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Verge Genomics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Verge Genomics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Verge Genomics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Verge Genomics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Verge Genomics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Verge Genomics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Verge Genomics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Verge Genomics Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Verge Genomics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • EndoGastric Solutions Inc-医療機器分野:企業M&A・提携分析
    Summary EndoGastric Solutions Inc (EGS), formerly EsophyX, Inc. is a medical equipment company that manufactures and markets gastroenterology and surgical products. The company’s products include esophy-x device and serosa-fuse fasteners. Its esophy-x device is used in reconstructing the gastroesoph …
  • Capcom Co. Ltd. (9697):企業の財務・戦略的SWOT分析
    Capcom Co. Ltd. (9697) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Verbund AG:企業の発電所・SWOT分析2018
    Verbund AG - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executi …
  • Entersoft SA (ENTER):企業の財務・戦略的SWOT分析
    Entersoft SA (ENTER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Rodin Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Rodin Therapeutics Inc (Rodin Therapeutics) discovers and develops novel medicines targeting epigenetics and novel chemical strategies for cognitive impairment of neurological and neuropsychiatric disorders. Its translational therapeutic strategy harnesses the power of epigenetic regulation …
  • LIXIL Group Corporation:企業の戦略・SWOT・財務情報
    LIXIL Group Corporation - Strategy, SWOT and Corporate Finance Report Summary LIXIL Group Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Relmada Therapeutics Inc (RLMDD):企業の財務・戦略的SWOT分析
    Summary Relmada Therapeutics Inc (Relmada Therapeutics), formerly Camp Nine Inc, is a pharmaceutical company that develops and commercializes products for the treatment of central nervous system (CNS) diseases. The company’s product pipeline includes REL-1017 d-Methadone, an antagonist for the treat …
  • Kuwait Food Company (Americana) KSCP:企業の戦略的SWOT分析
    Kuwait Food Company (Americana) KSCP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Scottish Power Ltd:企業の発電所・SWOT分析2018
    Scottish Power Ltd - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • Pacific Biosciences of California Inc (PACB):企業の財務・戦略的SWOT分析
    Pacific Biosciences of California Inc (PACB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Electrical Geodesics Inc:企業の製品パイプライン分析2018
    Summary Electrical Geodesics Inc (EGI) is a medical device company that designs, develops and commercializes non-invasive neuro diagnostic products used to monitor and interpret brain activity. The company offers clinical products such as geodesic EEG system 400 series, spike detection software, geo …
  • BioDot Inc-医療機器分野:企業M&A・提携分析
    Summary BioDot Inc (BioDot) is a healthcare products provider that manufactures low volumes of fluids and powder dispensing products. The company offers lateral flow, immunoblots, biojet, airjet, dry chemistry, bio chips, low volume PCR, glucose biosensors, biosensors, polyject and dispo powder disp …
  • Transat A.T. Inc:企業の戦略・SWOT・財務情報
    Transat A.T. Inc - Strategy, SWOT and Corporate Finance Report Summary Transat A.T. Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Pakistan Water and Power Development Authority-エネルギー分野:企業M&A・提携分析
    Summary Pakistan Water and Power Development Authority (WAPDA) is a government-owned public authority maintaining power and water in Pakistan. It is responsible for the development of hydel power and water sector projects in Pakistan. The authority plans and executes projects and schemes for the gen …
  • Nordic American Tankers Limited (NAT):石油・ガス:M&Aディール及び事業提携情報
    Summary Nordic American Tankers Limited (NAT) is a tanker company. It transports crude oil through its fleet of double-hull Suezmax tankers. The company operates its vessels on bareboat charters, time charters, and spot charters. NAT’s tankers are capable of carrying high volumes of oil and able to …
  • IDFC Ltd (IDFC):企業の財務・戦略的SWOT分析
    IDFC Ltd (IDFC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • LM Wind Power Holding AS-エネルギー分野:企業M&A・提携分析
    Summary LM Wind Power Holding AS (LM Wind Power), a subsidiary of General Electric Co, is a component supplier to the wind industry. The company designs and manufactures blades on modular technology featuring modular aerodynamics, modular structure and modular manufacturing tooling. Its blades have …
  • Orbit International Corp.:企業の戦略・SWOT・財務情報
    Orbit International Corp. - Strategy, SWOT and Corporate Finance Report Summary Orbit International Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Max Delbruck Center for Molecular Medicine:製薬・医療:M&Aディール及び事業提携情報
    Summary Max Delbruck Center for Molecular Medicine (MDC) is a biomedical research center that offers translating discoveries from molecular research into applications. The company’s research area services offer for cancer research, cardiovascular and metabolic disease, diseases of the nervous system …
  • Napp Pharmaceuticals Ltd:企業の戦略的SWOT分析
    Napp Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆